Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine, remifentanil and lidocaine for reduction of rocuronium-induced withdrawal response in pediatric anesthesia
ChiCTR2100050618Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine, remifentanil, lidocaine and rocuronium in pediatric anesthesia (4 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Withdrawal response after rocuronium injection. Started Sep 2021; status: recruiting.
02
Drugs
esketamineremifentanillidocainerocuronium
03
Conditions
pediatric anesthesia
Beyond the preview
Go deeper on ChiCTR2100050618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050618.